Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 19, Number 28, 2013

Articles

Free Content Editorial (Hot Topic: Targeting Histone Acetylation for Neuroprotection)
pp. 5017-5018(2)
Author: Contestabile, Antonio

Favourites:
ADD
Favourites:
ADD

Histone Acetylation in Neurodevelopment
pp. 5043-5050(8)
Authors: Contestabile, Antonio; Sintoni, Silvia

Favourites:
ADD

Open Access Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
pp. 5051-5064(14)
Authors: M. Valor, Luis; Viosca, Jose; P. Lopez-Atalaya, Jose; Barco, Angel

Favourites:
ADD
Favourites:
ADD

Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer´s Disease-like Phenotype of a Commonly Used Mouse Model
pp. 5076-5084(9)
Authors: Cuadrado-Tejedor, Mar; L. Ricobaraza, Ana; Torrijo, Rosana; Franco, Rafael; Garcia-Osta, Ana

Favourites:
ADD

Histone Post-translational Modifications in Huntington’s and Parkinson’s Diseases
pp. 5085-5092(8)
Authors: Emiliano Pena-Altamira, Luis; Polazzi, Elisabetta; Monti, Barbara

Favourites:
ADD

Histone Acetylation as a Potential Therapeutic Target in Motor Neuron Degenerative Diseases
pp. 5093-5104(12)
Authors: Garbes, Lutz; Riessland, Markus; Wirth, Brunhilde

Favourites:
ADD

Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery
pp. 5105-5120(16)
Authors: B. Fessler, Emily; L. Chibane, Fairouz; Wang, Zhifei; Chuang, De-Maw

Favourites:
ADD

Factors Affecting Residual Platelet Aggregation in Prasugrel Treated Patients
pp. 5121-5126(6)
Authors: Alexopoulos, Dimitrios; Xanthopoulou, Ioanna; Perperis, Angelos; Siapika, Argyro; Stavrou, Katerina; Tsoni, Evropi; Davlouros, Periklis; Hahalis, George

Favourites:
ADD

Targets for Anti-metastatic Drug Development
pp. 5127-5134(8)
Authors: Stock, Anna-Maria; Troost, Gabriele; Niggemann, Bernd; S. Zanker, Kurt; Entschladen, Frank

Favourites:
ADD

Cell-free DNA: Characteristics, Detection and its Applications in Myocardial Infarction
pp. 5135-5145(11)
Authors: Jing, Rongrong; Cui, Ming; Wang, Huimin; Ju, Shaoqing

Favourites:
ADD

New Strategy for High Throughput Screening of Anti-Influenza Virus M2 Ion Channel Inhibitors
pp. 5146-5155(10)
Authors: Li, Chufang; Long, Yan; Lin, Zuoxian; Jie, Yanling; Xiao, Yajuan; Yang, Lingzhi; Sun, Juanjuan; Ren, Yizhong; Chen, Ling; Li, Zhiyuan

Favourites:
ADD

Novel Insights into Biased Agonism at G Protein-Coupled Receptors and their Potential for Drug Design
pp. 5156-5166(11)
Authors: Marti-Solano, Maria; Guixa-Gonzalez, Ramon; Sanz, Ferran; Pastor, Manuel; Selent, Jana

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content